Funded Startups in King Of Prussia
Across the 9 most recent King of Prussia-funded entries shown, the largest disclosed round is Lyric at $91M (2023-08-18), which dwarfs the next-largest dis…
Across the 9 most recent King of Prussia-funded entries shown, the largest disclosed round is Lyric at $91M (2023-08-18), which dwarfs the next-largest disclosed amounts of $15M (FinPay, 2022-03-28) and $6M (Maxona Pharmaceuticals, 2021-05-05). Disclosed amounts are mostly clustered in the $2M–$5M range (e.g., Trevena $2M on 2024-07-08; InHomeTherapy $5M on 2024-05-29; Nocopi Technologies $5M on 2023-09-11; Quantic $2M on 2022-08-17).
The list also shows a temporal edge from 2021-05-05 (Maxona Pharmaceuticals) through 2025-04-14 (PowerPay), with multiple rounds tightening in 2024 (three disclosed rounds in May–July 2024: InHomeTherapy $5M on 2024-05-29; Trevena $2M on 2024-07-08; plus an undisclosed Series Unknown on 2025-04-14). Sector-wise, Financial Services appears in 3 of 9 entries (PowerPay, Lyric, FinPay), while 5 of 9 rows are labeled Series Unknown and 1 of 9 is undisclosed (PowerPay, 2025-04-14).
Most recent rounds
9 shownRelated listings
Frequently asked
Which disclosed round is the outlier in King of Prussia, and how does it compare to the rest of the disclosed amounts shown?
Lyric’s $91M (2023-08-18) is the only disclosed round above $50M in this set, far above the next-largest disclosed amounts of $15M (FinPay, 2022-03-28) and $6M (Maxona Pharmaceuticals, 2021-05-05). Most other disclosed rounds sit at $2M–$5M (e.g., Trevena $2M on 2024-07-08; InHomeTherapy $5M on 2024-05-29; Nocopi Technologies $5M on 2023-09-11).
Is there a concentration of rounds in a specific time window among the entries shown?
Yes. Three of the disclosed rounds fall within a compressed 2024 window (InHomeTherapy $5M on 2024-05-29; Trevena $2M on 2024-07-08), with another entry dated 2025-04-14 (PowerPay) extending the run into 2025. The overall date span for the 9 rows runs from 2021-05-05 (Maxona Pharmaceuticals) to 2025-04-14 (PowerPay).
Do any sectors appear over-represented in this King of Prussia list?
Financial Services is the clearest concentration, appearing in 3 of 9 entries: PowerPay (undisclosed, 2025-04-14), Lyric ($91M, 2023-08-18), and FinPay ($15M, 2022-03-28). Other sectors in the visible rows do not reach the 3-entry level (e.g., Biotechnology has 2 entries: Trevena and Maxona Pharmaceuticals).
How does the stage labeling mix look, and does it align with the largest disclosed rounds?
Series Unknown accounts for 5 of 9 entries (including PowerPay on 2025-04-14 as undisclosed), while the remaining labeled rounds include Seed (Quantic $2M on 2022-08-17), Series D (FinPay $15M on 2022-03-28), and Private Equity (Veterinary Practice Partners $100K on 2021-12-06). The two highest disclosed rounds shown—Lyric’s $91M (Series Unknown, 2023-08-18) and FinPay’s $15M (Series D, 2022-03-28)—straddle that mix rather than concentrating in a single stage label.
Which entries are worth a closer look because they sit at the extremes (smallest disclosed vs. undisclosed)?
On the small end of disclosed amounts, Veterinary Practice Partners is $100K (2021-12-06, Private Equity), which is much smaller than the rest of the disclosed rounds (e.g., Quantic $2M on 2022-08-17 and Trevena $2M on 2024-07-08). Separately, PowerPay (2025-04-14) is the only row marked undisclosed, so it can’t be compared by amount to the rest’s disclosed figures.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.